2020-2027 Analysis and Review Leuprolide Acetate Market

Leuprolide Acetate Market

Leuprolide Acetate Market By Clinical Application (Prostate Cancer, Endometriosis and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

30-05-2020 REP-HC-5101 40 Tables 110 pages Format

The leuprolide acetate market was valued at USD 575.6 Mn by 2019. Rising prevalence of endometriosis in women population and a significant increase in the occurrence of prostate cancer in men population worldwide primarily drive the leuprolide acetate market growth. Researchers are diligently engaged in developing leuprolide acetate drug formulation for the treatment of central precocious puberty among children population throughout the globe.

Leuprolide Acetate Market

Leuprolide acetate is a synthetic nonapeptide derivative of the gonadotropin-releasing hormone which is employed for its diverse clinical applications such as endometriosis, prostate cancer, and central precocious puberty, etc. The drug is associated with severe side effects such as swelling, rapid weight gain, seizures, painful urination, etc.

The major segments related to the leuprolide acetate market are: 

By Clinical Application (2017–2027; US$ Mn)

Prostate Cancer

Endometriosis

Others

By Distribution Channel (2017–2027; US$ Mn)

Hospital Pharmacy

Retail Pharmacy

Others

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global leuprolide acetate market
  • The overall segmentation of the leuprolide acetate market, by clinical application, distribution channel, and geography is minutely studied. Endometriosis and hospital pharmacy are dominating the clinical application and distribution channel segments respectively
  • Rising prevalence of endometriosis or uterine fibroids among women population worldwide
  • Clinical studies have revealed the therapeutic efficacy and safety of leuprolide acetate in the treatment of symptoms only associated with prostate cancer in men population throughout the globe

Report gist?

  • The study of the global leuprolide acetate market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers a qualitative and quantitative analysis of the overall market segmented on the basis of clinical application and distribution channel and categorization of the same at the geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. The compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the pharmaceutical manufacturers actively engaged in the production and marketing of leuprolide acetate due to the  rising prevalence of endometriosis among women population worldwide
  • The report will benefit researchers engaged in the development of leuprolide acetate drug formulation for the treatment of central precocious puberty in children throughout the globe
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to leuprolide acetate market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Endometriosis is leading the clinical application segment for the leuprolide acetate market. According to the latest research citings presented by the World Health Organization (WHO), approximately 176 million women worldwide are suffering from endometriosis. It is considered a recurring disease that is persistent in nature and causes fatigue, dysmenorrhea, pelvic pain, and infertility, etc. It severely affects the social life of a woman during her reproductive age. Prostate cancer is going to register rampant market growth during the forecast period on account of the rising prevalence of prostate cancer in men population worldwide. As per the latest research citings provided by the World Cancer Research Fund (WCRF), in 2018 approximately 1.3 million new cases of prostate cancer were reported throughout the globe.

Hospital pharmacy is presently reigning the distribution channel segment for the leuprolide acetate market. The drug posology of the drug varies according to its clinical application, hence it is imperative for the hospital pharmacist to precise dispense the medication as per the doctor’s recommendation. Retail pharmacy is expected to showcase rapid market growth in the near future due to flourishing generic drugs market demand in the developing regions and its ability to provide medicines to patients residing in remote locations.

North America is currently spearheading the geography segment for the leuprolide acetate market. The rising prevalence of prostate cancer primarily drives market growth in the region. As per the latest statistics provided by the Center for Disease Control and Prevention (CDC) in 2019, approximately 191,930 men in the United States were reported with prostate cancer. Additionally, the presence of key players such as Abbvie, Inc., Sandoz, Inc., Tolmar Pharmaceuticals, etc., further propel the market growth in the region. Europe is the second-largest regional segment for the leuprolide acetate market. Strategic collaboration between pharmaceutical companies and research academia for the novel drug development of leuprolide acetate for the treatment of central precocious puberty among children determines the market growth in the region. Asia Pacific is anticipated to be the fastest-growing regional segment for the leuprolide acetate market. Rising prevalence of endometriosis among women population and flourishing generic drugs market together accentuate the market growth in the Asia Pacific region.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.